HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast · Sean P. Kane, PharmD; Khyati Patel, PharmD

173 - Balancing Access and Safety: The FDA's Prescription Drug Risk Mitigation Strategy (REMS)

·42 min

This episode explains the FDA's Risk Evaluation and Mitigation Strategy (REMS) program, covering its definition, history, purpose, and impact on pharmacists and healthcare providers.

Listen to the show on

Apple Podcasts Spotify

More from HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast